Advertisement XTend Medical initiates diabetic telehealth program - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

XTend Medical initiates diabetic telehealth program

XTend Medical has started a remote diabetic monitoring program with a target of 500 patients to be part of the initial program.

The program, facilitated through local physicians in Southern California, will remotely monitor diabetic patients through the XTend Medical Disease Management Program. The patients will be able to take their glucose readings and transmit the results to the participating physicians via the Eocene transmitter. Once the glucose meter is cradled to Eocene unit, the plug-in system utilizes a standard phone line to send the encrypted patient data to a central server for review by the physician. Once the data is reviewed by the physician, then any adjustments in medication, compliance with testing, and/or any necessary follow-up visits can be relayed immediately to the patient.

Paul Lisenby, CEO of XTend Medical, said: “XTend Medical is now poised to implement this system nationwide to any healthcare company looking to remotely monitor their diabetic patients.”